[1]
“Risk of Malignancy in Bethesda Category III Thyroid Nodules with Nuclear Atypia: A Retrospective Study Based on Thyroidectomy Findings”, J. Can. Res. Updates, vol. 15, no. 1, pp. 11–15, Jan. 2026, doi: 10.30683/1929-2279.2026.15.02.